+41 58 261 5000
Restructuring and insolvency
Industrials and manufacturing
Pharmaceuticals and life sciences
Rolf Watter has broad experience in all types of M&A transactions, including defence mandates. He also specializes in corporate governance questions.
He is a board member of the listed AP Alternative Portfolio and of the privately held Faber Castell (Holding). He used to be chairman of PostFinance (2012/2021), CEVA Logistics (2018/2019) and of Nobel Biocare (2012/2014; member 2007/2012); further he was a board member in a number of other Swiss listed companies, namely Aryzta, Zurich Insurance Group, Syngenta, Centerpulse, and Forbo. He was a long-time member of the Regulatory Board of the SIX Swiss Exchange (2003/2022).
Rolf teaches as a professor at the University of Zurich since 1996 and is an editor of the GesKR and the Basler Kommentare on the Code of Obligations II, the Financial Infrastructure Act, the Banking and the Merger Act. He regularly publishes in his fields of work.